Mechanistically, IL-17 acts on synovial fibroblasts and stromal cells, induces RANKL and matrix metalloproteinases, and cooperates with TNF and IL-6, which accelerates bone erosion and cartilage damage in rheumatoid arthritis [35]. Here, IL17A is linked to rheumatoid arthritis.